QQQ1.12%

Trending

BCRX0.43%

Info

home Symbol QDELnews

Exchange: NASDAQ·Updated 07:34 PM EDT

QDELQuidelortho Corp

$16.05

$0.53

(3.20%)

Today

Closed $16.05

$0.02

(0.13%)

After Hours

EarningsAug 6

Mkt Cap$1.13B

Vol913,044.00

News

all

press releases

QuidelOrtho to Report Second Quarter 2026 Financial Results

QuidelOrtho to Report Second Quarter 2026 Financial Results QuidelOrtho to Report Second Quarter 2026 Financial Results PR Newswire SAN DIEGO, July 24, 2026 SAN DIEGO, July 24, 2026 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL) (the "Company" or "QuidelOrtho"), a leading global provider of...

PR Newswire

More News

Reasons to Add QuidelOrtho Stock in Your Portfolio for Now

QDEL's strong portfolio, cost-saving progress and mixed first-quarter results support growth, though respiratory reliance remains a risk.

Zacks

DGX Stock Up on Q2 Earnings & Revenue Beat, '26 View Raised

Quest Diagnostics shares rise as second-quarter earnings and revenues beat estimates, testing demand surges and the company raises its 2026 outlook.

Zacks

Beyond Fentanyl: How the Drug Crisis Is Changing

Beyond Fentanyl: How the Drug Crisis Is Changing Beyond Fentanyl: How the Drug Crisis Is Changing PR Newswire SAN DIEGO, July 23, 2026 SAN DIEGO, July 23, 2026 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL), a global leader of in vitro diagnostics, has released episode 59 of its Science...

PR Newswire

Kaskela Law Firm Announces Investigation of QuidelOrtho Corp. (QDEL) and Encourages Long-Term QDEL Shareholders with Investment Losses to Contact the Firm

Investor litigation firm Kaskela Law announces that it is investigating QuidelOrtho Corporation (Nasdaq: QDEL) (QuidelOrtho) on behalf of the companys long-term investors. Click here for additional information: https://kaskelalaw.com/case/quidelortho-corp/ Recently a securities fraud complaint was...

Business Wire

Zacks Industry Outlook Highlights Terumo, QuidelOrtho, Lumexa Imaging and Brainsway

Terumo stands out as medical products companies navigate cost pressures with innovation, pricing actions and demand for advanced diagnostics supporting growth.

Zacks

4 Medical Products Stocks Poised to Win Despite Industry Headwinds

Terumo, QuidelOrtho, Lumexa Imaging and BrainsWay are tackling industry headwinds through innovation, pricing and execution as healthcare demand stays resilient.

Zacks

QuidelOrtho Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

QuidelOrtho Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) QuidelOrtho Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) PR Newswire SAN DIEGO, July 15, 2026 SAN DIEGO, July 15, 2026 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL)("QuidelOrtho"), a leading...

PR Newswire

QuidelOrtho (QDEL) Moves 32.2% Higher: Will This Strength Last?

QuidelOrtho (QDEL) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

Zacks

QDEL Stock Eyes Best Day In Over A Year — Point-Of-Care Sale Talks Ignite Rally

QuidelOrtho is in talks to sell its point-of-care testing unit behind the rapid antigen tests for Covid and flu, Financial Times reported over the weekend.

Stocktwits

...

Advertisement|Remove ads.